Botanix Pharmaceuticals Stock Forecast, Price & News

Botanix Pharmaceuticals (ASX:BOT) Frequently Asked Questions

What stocks does MarketBeat like better than Botanix Pharmaceuticals?

Wall Street analysts have given Botanix Pharmaceuticals a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Botanix Pharmaceuticals wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

How were Botanix Pharmaceuticals' earnings last quarter?

Botanix Pharmaceuticals Limited (ASX:BOT) announced its quarterly earnings results on Thursday, February, 28th. The company reported ($0.01) earnings per share (EPS) for the quarter.
View Botanix Pharmaceuticals' earnings history.

Who are Botanix Pharmaceuticals' key executives?

Botanix Pharmaceuticals' management team includes the following people:

• Mr. Vincent P. Ippolito, MD, Pres & Exec. Chairman (Age 62, Pay $808.16k)
• Dr. Henry William Bosch, Chief Scientific Officer & Exec. Director
• Mr. Matthew Callahan L.L.B., M.B.A., MBA LLB, Exec. Director (Age 48, Pay $481.08k)
• Dr. Clarence L. Young, Chief Medical Officer (Age 65)
• Ms. Lynda Berne, Head of Commercial
• Mr. Simon Robertson C.A., B.Bus, M Appl. Fin, CA, Company Sec.

Who are some of Botanix Pharmaceuticals' key competitors?

Some companies that are related to Botanix Pharmaceuticals include (TNGN) (TNGN), 3SBio (TRSBF), 45525 (CUR.TO) (CUR), Abattis Bioceuticals (ATTBF), Abzena (ABZA), Acrux (ACR), Actinogen Medical (ACW), AdAlta (1AD), Admedus (AHZ), Algernon Pharmaceuticals (AGNPF), Almirall (LBTSF), Amarantus BioScience (AMBS), Amplia Therapeutics (ATX), Anatara Lifesciences (ANR) and Annovis Bio (ANVS).
View all of BOT's competitors.

What other stocks do shareholders of Botanix Pharmaceuticals own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Botanix Pharmaceuticals investors own include AgraFlora Organics International (AGFAF), Byron Energy (BYE), Harmony Gold Mining (HMY), Puhui Wealth Investment Management (PHCF), NIKE (NKE), Michael Hill International (MHJ), Lynas Rare Earths (LYC), Cobalt 27 Capital (KBLT), Eclipx Group (ECX) and Bod Australia (BDA).

What is Botanix Pharmaceuticals' stock symbol?

Botanix Pharmaceuticals trades on the ASX under the ticker symbol "BOT."

How much money does Botanix Pharmaceuticals make?

Botanix Pharmaceuticals has a market capitalization of $0.00 and generates $6.89 million in revenue each year.

How many employees does Botanix Pharmaceuticals have?

Botanix Pharmaceuticals employs 1 workers across the globe.

What is Botanix Pharmaceuticals' official website?

The official website for Botanix Pharmaceuticals is www.botanixpharma.com.

Where are Botanix Pharmaceuticals' headquarters?

Botanix Pharmaceuticals is headquartered at Ground Floor, 16 Ord St, PERTH, WAS 6005, Australia.

How can I contact Botanix Pharmaceuticals?

Botanix Pharmaceuticals' mailing address is Ground Floor, 16 Ord St, PERTH, WAS 6005, Australia. The company can be reached via phone at +61-8-94820580.